The effect of drugs on thrombolytric cardiac enzymes, creatine kinase and Phospho Creatine Kinase-MB in myocardial Infarctionâ €

Author: Pushpa Latha

"The effect of drugs on thrombolytric cardiac enzymes, creatine kinase and Phospho Creatine Kinase-MB in myocardial infarction.

MYOCARDIAL INFARCTION

Myocardial infarction refers to a dynamic process by which one or more regions of the experience of a muscle severe heart and prolonged decrease in oxygen supply due to inadequate coronary blood away, necrosis, or death instead of fabric the myocardium.

The onset of myocardial infarction or sudden process in May and gradual progression to complete the event is about 3 to 6 hours.

PREVALENCE

Myocardial infarction is the leading cause of death in the United States (U.S.), and in most industrialized countries in the world. Approximately 800,000 people in the United States are affected, and despite a greater awareness of symptoms, 250000 die before presentation to hospital. 4 The survival rate of patients hospitalized in the United States with MI is about 90% to 95%. This represents a significant improvement of survival and is linked the improvement of emergency medical assistance and treatment strategies.

In general, MI can occur at any age, but its incidence increases with age. The actual impact depends on predisposing risk factors for atherosclerosis, which are discussed below. Approximately 50% of all the MI in the United States occur among people younger than age 65. However, in the future, as changing demographics and the average age of the population increases, a greater percentage of patients with MI will be over 65 years.

Men are more likely than women but the risk is more women than men after menopause.

CORONARY ARTERIES

The coronary arteries, the capillaries of the offer with myocardial blood

The right coronary artery (RCA) provides the atrium and the right ventricle, the lower part of the left ventricle, the posterior wall of the septum and the SA and AV nodes

The left coronary artery (LCA) is composed of two major branchiate left anterior (LAD) and circumflex (LCX).

The LAD artery supplies below the anterior wall of left ventricle, ventricular septum before and left ventricular apex.

The LCX artery supplies blood to the lateral and posterior left ventricle.

CARDIAC ENZYMES

Levels Cardiac markers rise in overtime. Therefore, enzymes are usually a model series of admission and up to 6.24 hours 3 samples were obtained.

Enzymes commonly evaluated CK, CKMB, LDH, TroponinT & I.

CK-MB ratio indicates the extent damaged heart muscle. The higher the ratio, the more damage the heart muscle. Troponins are preferred markers of myocardial injury and heart, they are very specific and is thought to rise before permanent injury develops.

Increased troponin concentrations should not be used by themselves to decide on a heart attack. Troponin will remain high for 1-2 weeks after MI facilitate the diagnosis if the patient end of an old MI than others to the EC will not be raised unless Reinfarction was product.

Elevated cardiac enzymes in myocardial infarction

Enzyme The higher peaks in the standard normal value ratio CKMB

CK 12 h 16-30hrs 3-5 days 35-232IU / L

CKMB 4-8 hours 24 hours 72 hours <51IU / L <6%

Troponin I 3-6 h 20 h 14 days 0.0-0.4 ng / ml

Troponin T 2-4 hours 14 hours 8-12 days 0.0-0.1 ng / ml

LDH 12 h 12-24 h 10 days 100-190 IU / L

PATHOPHYSIOLOGY

Most often sites of MI in the left ventricle, the heart chamber which has the largest workload. Tissue changes in the myocardium are related to the extent to which the cells were deprived of oxygen. Total deprivation results in an area of infarction in which cells die and the tissue is necrotic.

Necrosis in this area is evident in 5 to 6 hours after occlusion. In response to this necrosis of the body increase its revenues from leukocytes, which helps eliminate dead cells. As collateral circulation expands, it brings fibroblasts, which form a connective tissue scar in the area of infarction. Usually, the formation of fibrous scar tissue is complete in 2 to 3 months.

Surrounding the infarct zone is an area less severely damaged injury. It deteriorated in May and thus extend the field of infarction or guarantees traffic in May, he returned to his office within 2 weeks.

The area outside the most damage of ischemia of the area that borders the area of the accident. The cells in this area are weakened by the decrease in oxygen supply, but the function may return normally 2 to 3 weeks after the onset of occlusion.

RISK FACTORS

There are two types of risk factors for heart attack, including

1. Inherited factors
2. Acquired factors

Inherited factors

These are risk factors you are born with that can not be changed, but can be improved with medical management and changes in style of life. Here are the most at risk

• persons with inherited hypertension
• persons with inherited low levels HDL or high levels of LDL
• people with a family history of heart disease of aging men and women
• people with diabetes mellitus [type 1 diabetes]
• women after the onset of menopause, generally, men are risk at an earlier age than women, but after the women are also at risk

Acquired factors

These are risk factors that are caused by activities that we have chosen to include in our lives that can be managed through lifestyle changes and clinical care. Here are the most at risk

• People with hypertension
• those who acquired the level low HDL or high LDL
• cigarette smokers
• persons who are under great stress
• individual who lives a sedentary life
• persons overweight by 30% or more

  TYPE myocardial infarction

1. Different degrees of damage to heart muscle,

Area of necrosis: dead muscle heart caused by deprivation of oxygen and is complete, irreversible damage

Zone of injury: the region of heart muscle that surround the area of necrosis, inflammation and injury, but still viable, if the oxygen can be restored.

Area of ischemia: the region of the heart muscle that surround the area of injury, which is ischemic and viable, not in danger unless the extension of the infarction occurs.

2. According to the layers of heart muscle involved, MI can be classified as

Transmural or Q wave myocardial infarction; area of necrosis occurs throughout the thickness of the heart muscle. Subendocardial or non-transmural infarction; area of necrosis is limited to the inner layer of the heart muscle.

3. Localization of MI is identified as the location of the damaged heart muscle in the lower left ventricle, previous and subsequent Side —

Left ventricle is the most common and dangerous for MI location, because it is the main pumping chamber of the heart

Right ventricular infarction occurs I junction with damage to the bottom and / or posterior wall of left ventricle

4. Region heart muscle is damaged as determined by the coronary artery is clogged

Left main coronary artery

Circumflex branch

Anterior ascending branch

Great cardiac vein

Middle cardiac vein

Right cardiac vein

CLINICAL MANIFESTATIONS

1) Chest pain

• not relieved by rest during sublingual therapy vasodilator
• stable under severe sternal chest pain of a crushing and pressing nature
• May radiate to the arm, neck, jaw and shoulders
• still more than 15 minutes
• May cause anxiety and fear

2) diaphoresis

3) Hypertension or hypotension

4) Bradycardia or tachycardia

5) palpitations, severe anxiety, dyspnea

6) The disorientation confusion and agitation

7) Fainting, weakness marked

Nausea, vomiting, hiccough

9) Atypical symptoms such as epigastric pain, abdominal pain, dull pain or tingling sensation, shortness of breath, fatigue

Dignostic EVALUATION

1. ECG Changes

Usually occur within 2 – 12 hours, but take 72 May – 96 hours.

Necrotic, injured and ischemic tissue change depolarization and ventricular repolarization

ST segment depression and wave T indicate a reversal of ischemia

ST indicates the altitude of an injury model

• Anterior small V3 – Leads V4
• Anterior wide V2 – V5 leads
• Anteroseptal leads V1-V3
• Posterior V1 – V2 leads gradual R wave and ST
• Anterolateral V4 – V6, I, led Avl
• Apical V5 – V6 leads
• Inferior lead II, III and AVF [mutual]

2. Elevated serum enzymes and isoenzymes

Enzymes are drawn in a series of general on admission and every 6 – 24 hours up to 3 samples were obtained. Then the enzyme activity is correlated to the extent of damage of cardiac muscle

Enzymes are commonly evaluated include CK, LDH, CK-MB, AST, Troponin I, troponin T. [Fig.4]

LDH 2 is normally greater than LDH 1, except when the heart muscle is damaged a reversal occurs

3. Other findings:

White blood cells and raise the speed of sedimentation due to inflammatory processes associated with heart muscle damage.

Radionuclide imaging allows the recognition of areas of decreased perfusion

Emission tomography position determines the presence of muscle injury reversible and irreversible heart or necrotic tissue, which extends to the victim's heart muscle has responded to treatment may also be determined

MANAGEMENT

Therapy aims at the protection of ischemia and cardiac tissue injured to preserve function muscle, reduce the size of infarction, and prevent death. Innovative ways to provide rapid restoration of coronary blood flow, and the use of pharmacological agents to improve oxygen supply and demand, reduce and / or prevent and disarrhythmias inhibit the progression of coronary artery disease.

1. Opioid analgesic therapy: Morphine is used to relieve pain, improve cardiac hemodynamics by reducing preload and after charging to relieve anxiety.

Meperidine [Demerol] is useful for pain management in patients of morphine against or susceptibility to depression breathing.

2. Anxiolytic agents: Benzodiazepines are used analgesics more complicated when anxiety chest pain and its relief

3. Antiplatelet agents: Aspirin interfere with the functioning of the enzyme cyclo-oxygenase and inhibits the formation of thromboxane A2. Within minutes aspirin prevents other platelet activation and reduce platelet adhesion and cohesion

Other antiplatelet are, Clopidogrel, Ticlopidine, Dipyridamole, these agents, particularly clopidogrel May be useful for patients who have a true allergy to aspirin and sometimes can be used with the combination with aspirin.

4. Additional oxygen: oxygen additional should be administered. The reason being is the assurance that erythrocytes will be saturated to the maximum carrying capacity. Because MI affect the circulatory function of the heart, the extraction of oxygen by the heart and other tissues May be decreased.

5. Nitrates: Nitrates intravenously should be administered in MI, persistent ischemia, hypertension or a large anterior wall MI. Nitrates are metabolized to nitric oxide in vascular endothelium. Nitric oxide relaxes the muscle vascular smooth and dilates blood vessels light. Vasodilation reduces cardiac preload and after load, and decreases the myocardial oxygen requirements. Vasodilatation improves coronary artery blood flow through the obstructed vessels and through collateral vessels. When administered by sublingually or intravenously, nitroglycerin has a rapid onset of action.

6. Beta-adrenergic blockers: Beta blockers are recommended within 12 hours the symptoms of myocardial infarction and are kept indefinitely. Beta-blockers reduce the rate and force of contraction myocardium and decreases the overall demand of myocardial oxygen. During the acute phase of myocardial infarction Betablockers May be initiated by intravenous

7. Heparin: unfractionated heparin: unfractionated heparin intravenously is recommended undergoing revascularization percutaneous. It is also recommended in patients who receive fibrinolytic therapy and non-selective fibrinolytic agents such as urokinase, streptokinase and anistreplace. Heparin inhibits the additional training and propagation of thrombus, effective when administered intravenously or subcutaneously.

Low-molecular-weight-heparin: can be given to customers not treated MI with fibrinolytic therapy

8. Fibrinolytic or thrombolytic agents: Fibrinolytic is shown with ST segment elevation. Plasminogen activators restore coronary vessels obstructed by dissolving thrombus. Plasminogen activators have been shown to restore coronary blood flow 50% to 80% of MI patients. The successful use of fibrinolytic agents provides a survival benefit is maintained for years. Reteplase has been shown to produce slightly higher 60 – and 90-minute angiographic rates accelerated alteplase permeability, events equal reaction rates.

However, the highest permeability to the top has not led to an advantage survival to 30 days of follow-up. The most critical in achieving success is variable fibrinolysis time of onset of symptoms to administration of the drug. A fibrinolytic is more effective when the "door to needle" time is 30 minutes or less.

9. Angiotensin inhibitors of angiotensin converting enzyme: Oral ACEI is recommended in the first 24 hours of onset of symptoms of MI, the reduction of myocardial after load through vasodilatation.

10. Anti dysarrhythmic agents: Lidocaine reduces irritability ventricle, which occurs after MI.

11. Calcium channel blockers: Improving the balance between supply and the oxygen demand by decreasing Heart Rate, blood pressure and dilated coronary vessels.

Diltiazem has been shown that the incidence of Reinfarction decreased in patients with non-Q-Wave MIS.

12. Percutaneous Coronary Intervention [Fig-15]: Opening mechanics of coronary vessel can be achieved during the evolution of infarction. A balloon tipped catheter is introduced through a wire guide in a coronary vessel with a non-atheromatous calcified lesion. The balloon of the probe is inflated, causing disruption of the intima and the evolution of atheroma. The result is an increase in the diameter of the coronary vessel light and improving blood flow below of the lesion.

Percutaneous coronary intervention is an alternative therapy to fibrinolysis Restoration of coronary blood flow in an MI can be achieved mechanically by percutaneous coronary intervention (PCI). Mechanical revascularization by PCI is used as therapy Primary as an alternative to fibrinolysis when thrombolysis is not clearly indicated or against inappropriate. PCI can successfully restore the blood flow coronary artery in 90% to 95% of MI patients.

13. Surgical Revascularization: Emergent or urgent coronary bypass surgery is justified in part of the failure of the percutaneous intervention in patients with hemodynamic instability and coronary anatomy suitable for surgery transplants. Surgical revascularization is also indicated as part of the mechanical complications of MI such as ventricular septal defect, without breaking the wall, or acute mitral regurgitation. Restoration of coronary blood flow in an emergency coronary artery bypass grafting (CABG) myocardial will limit injury and cell death if it is done in 2 or 3 hours of symptom onset. Emergency CABG has a higher risk of morbidity perioperative (bleeding and MI extension) and mortality than CABG choice. The risk of operative mortality in cases of emergency CABG is increased in patients who are in cardiogenic shock, the coronary bypass surgery with the previous ones, and multi-vessel disease. On the other hand, CABG confers emergency survival in patients with recurrent ischemia post-MI, whose anatomy is unsuitable for coronary revascularization compatibility with PCI. Elective CABG improves survival post-MI patients with left main artery disease, three vessel disease, or two vessels disease that is not amenable to PCI. The timing of elections bypass post-MI is controversial, but retrospective studies show that when CABG is performed as early as 3 to 7 days post-myocardial infarction, operative mortality is equivalent to bypass surgery performed on the non-MI patients.

14. Cardiac Stress Testing: cardiac stress testing post-MI has established the value of risk stratification and assessment functional capacity. Stress tests are not recommended in the few days post-MI. Only the sub-maximal stress tests should be performed in the stability patients from 4 to 7 days after MI. Exercise testing identifies patients with residual ischaemia further efforts to revascularization. Exercise test also provides prognostic information and acts as a guide for post-MI exercise prescription and cardiac rehabilitation.

15. Lipid Management: All patients post-MI must be on an American Heart Association Step II diet (<200 mg cholesterol per day, <7% of total calories from saturated fat). Post-MI patients with LDL cholesterol> 100 mg / dL on a Step II diet is recommended to be on drug therapy to lower LDL-cholesterol <100 mg / dL. Post-MI patients with levels of HDL-cholesterol <35 mg / dL on Step II diet is recommended to participate in a regular exercise program and therapy to increase HDL-cholesterol. 4 Recent data indicate all MI patients should be on statins, regardless of lipid levels or food

16. In the long-term medication: Most oral medications in the hospital at the time of MI will continue long term. Treatment by aspirin and beta-blockade continues indefinitely in all patients. CIRA is continued indefinitely in patients with heart failure congestive heart failure, left ventricular dysfunction (ejection fraction <0.40), hypertension or diabetes. A lipid lowering agent, particularly a statin, in addition to diet modification continues indefinitely  

17. Cardiac Rehabilitation: Cardiac rehabilitation provides a place to continue education, re-application of the change in lifestyle and adherence to a prescription therapies for the recovery of MI, which includes exercise training. Participation in cardiac rehabilitation programs post-MI is associated with a decrease in mortality and cardiac morbidity. Other benefits include improving the quality of life, functional capacity and help Name. A minority of post-MI patients actually participate in development of cardiac rehabilitation programs, either because of the lack of structured programs, physician referral, poor patient motivation, noncompliance, or financial constraints.

NECESSITY OF THE STUDY

Reperfusion therapy, in which we include thrombolytic therapy and percutaneous coronary intervention (PCI), which includes angioplasty and stent placement, is the greatest advance in the treatment of acute myocardial infarction

Studies have shown that many patients with AMI who are eligible for reperfusion therapy do not receive it. In addition, those who receive, time of administration of therapy thrombolytic, or "door to needle time" is often delayed, thereby jeopardizing the myocardium, leading to greater morbidity and mortality.

Clinical criteria and parameters of the simple ECG have limited value for non-invasive diagnosis of myocardial reperfusion. Other methods, such as ST segment monitoring and kinetic analysis of biochemical markers, may also enhance early identification of the IRA Related Artery infarction (), the total CK, CK-MB isoenzymes seem the most promising biochemical markers.

In addition, the proposed thresholds for diagnosis of reperfusion are generally from time-to-peak "values. This excludes the early diagnosis, because the values of peak CK plasma is met, on averages 9 – + 6 hours after thrombolysis.

Determination of total and plasma CK MB concentration provides accuracy superior to any other currently available method for diagnosis of acute MI.

In addition to providing an accurate diagnosis of acute MI, CK MB quantitative assays can also be used to obtain an accurate estimate of infarct size. In recent years, accuracy in diagnosis Acute MI was even greater importance, since the choice and timing of a variety of diagnostic and therapeutic options following unit coronary care admission hinge that infarction occurred. In addition, the advent of thrombolytic therapy acute MI has stressed the need for the most sensitive biochemical markers of necrosis in the first hour. The eventual realization that the restoration of blood flow was the main mechanism for reducing the size of infarction led to a therapeutic approach dominated by thrombolysis and literally by the use of interventions to open vessels and keep them open.

The fact is that the main advantages of using a drug could be demonstrated if the drug was given before the period of ischemia.

However, the greatest benefit in the management of patients with myocardial infarction has undoubtedly been the restoration of blood flow as soon as possible after occlusion

The objective of this study is to determine the reperfusion injury exacerbated by thrombolytic drugs in Myocardial Infarction in the process of elevation of cardiac enzymes and summits just to normal within 24 hours, the prevention of injuries and prolonged myocardial ischemia tissues.

However, the objective was to prospectively evaluate the biochemical markers for diagnosing permeability early after coronary thrombolysis IV for acute myocardial infarction.

STATEMENT OF THE PROBLEM

"The effect of drugs on thrombolytric cardiac enzymes, creatine kinase and Phospho Creatine Kinase-MB in myocardial infarction.

OBJECTIVES

• To assess the effect of thrombolytic drugs on cardiac enzymes.
• To compare the effect thrombolytic drugs and thrombolytic drugs on cardiac enzymes
• To determine the importance of thrombolytics to a patient with myocardial infarction
• To propose guidelines for public education regarding the research early in medical aid early pains in the chest.

OPERATIONAL DEFIITIONS

Effect: the result or outcome

Thrombolytic drugs: Drugs used to dissolve blood clots

CPK: A cardiac isoenzyme which releases into the bloodstream at a high level when an injury occurs to the heart. It is also known as Creatine or Creatine Kinase Phophokinase.

CK-MB: There is also a cardiac isoenzyme releases in the blood of the heart muscle during a heart wound

Myocardial infarction: a region of necrosis of the myocardium caused by an interruption of blood supply to the heart, usually due to the occlusion of a coronary artery.

HYPOTHESIS

"Thrombolytic agents is effective on the lower levels of peak cardiac enzymes, CK and CK-MB "

LIMITATIONS

Coronary care unit: Data from this research is applicable in the parameters of the coronary care unit.

Age: Customers are selected only among 35 to 65 years of age.

Myocardial infarction: This provision is also applicable for clients who were admitted to hospital within 6 hours after the onset of chest pain with myocardial infarction who received Inj. Metalyse.

Acute coronary syndrome: Customers who are admitted after 6 hours of onset of chest pain with acute coronary syndrome are included in the control group.

METHODOLOGY:

This study was carried out by an experimental method of research design within the parameters of the Coronary Care Unit of the Hospital Dubai, United Arab Emirates a series of patients receiving IV Metalyse [tenecteplase] MI May 2006 to November 2006 were included in this study.

RESEARCH DESIGN:

This study uses comparative design.

Parameters:

This study was conducted in patients regardless of age, sex and nationality, which were admitted to coronary care unit by emergency departments in the hospital in Dubai, United Arab Emirates

SAMPLE SIZE:

This study included 60 clients, men and women, without distinction of nationality, 35 years of age 65. Among the 60 clients 30 were taken as experimental group and 30 others regarded as control group.

Sampling technique:

The samples are selected as a practice sample into two groups, experience and control groups. Customers who received thrombolytic agents within 6 hours after the onset of chest pain are selected as an experimental group, and clients that were submitted after the end of 6 hours of onset of chest pain not received thrombolytics, are selected as control group. All patients had the diagnosis of myocardial infarction confirmed Subsequent elevation of creatine kinase two [CK] and CK-MB isoenzyme levels. Metalyse IV is administered at a dose of 6000 units to 9000 units depending on the weight of patients. Patients with severe MI who were admitted to the CCU over 6 hours of onset of pain have also been included.

  DATA COLLECTION PROCEDURE:

Data of the study are collected by an instrument, which consists of 22 articles, including sample number, age and sex. Religion, nationality, occupation, dietary habits, lifestyle onset of chest pain, the date and time of admission, signs and symptoms, signs life, type of MI, the protocol for thrombolytic therapy, the levels of cardiac enzymes after thrombolytic therapy, medications received and the date of discharge.

A study shows that most customers who had MI was sub-continent, constituting 63.3% and the minority which constitutes only 1.6%, Great British and Turkey. 3.3% of customers were Egyptians and Syrians. Bangladeshis composed of 6.6% and Pakistanis were approximately 21.6%. Only 9.9% of customers who were MI Dubai Nationals. Among them, 46.6% of clients were aged between 46 — 55 years and 41.6% of clients are between 36 – 45 years and the remaining 11.6% of clients have between 56 – 65 years of age.

36.2% of clients acute syndrome surgery and did not receive thrombolytics. Rest of the clientele was true MI and most of them were thrombolysed. However, all clients have undergone coronary angioplasty. Of these customers have a single client normal coronary vessels, two were of a mild coronary stenosis to conservative medical treatment and 4 with the main customers triple vessel block have been issued for CABG. Rest of the clients were treated with percutaneous coronary angioplasty to LAD [50%], ARC [21.6%] and circumflex [13.5%].

It is also clear from the study that Most Indians are affected by the MI and the main factors are smoking, stress and lack of knowledge about the disease.

Based on Chi-Square difference the association between normalization of cardiac enzymes in the study groups are as follows —

In the experimental group, 30 clients received Inj. Metalyse. of them except 4 clients, 26 other reports of customers since the cardiac enzymes normalized within 24 hours after admission and administration the thrombolytic agent.

In control group, 30 clients of the reports of blood for the normalization of cardiac enzymes were anlysed, where we 27 customers have found the reports showed higher levels of cardiac enzymes after 24 hours of admission.

1. Critical Value 14.56, P value <0.05 and rejected the null hypothesis

Inj. Metalyse has a good effect on the heart muscle with Critical Value-14, 56, Probability value <0.05, as evidenced by the fall in peak levels of cardiac enzymes CK and CK-MB within 24 hours after receiving thrombolytic agent.

DISCUSSION

Tenecteplase [Metalyse] is a recombinant fibrin-specific plasminogen activator. It binds to the fibrin of thrombosis and selectively converts thrombus bound plasminogen to plasmin, which degrades fibrin matrix of thrombi. Tenecteplase is eliminated from circulation by binding to specific receptors in the liver, followed by catabolism of small peptides.

After single intravenous bolus of tenecteplase in patients with acute myocardial infarction, tenecteplase antigen exhibits biphasic elimination from plasma. There are no dependence the dose tenecteplase clearance at therapeutic doses.

The first dominant half-life of 24 + _5.5 [mean = /-SD] min. half-life of 129 _87 + Minutes, and plasma clearance was 119 + _49 ml / min

The main conclusion of this study is the beginning of the peak of total CPK and CK-MB

isoenzymes were identified after successful reperfusion therapy Metalyse. The peak CPK level reached in 12 hours and CK-MB were displaced within 6 hours. The study reveals that cardiac enzymes and reached levels normalized within 24 hours time in the experimental group which received thrombolytic agents within 6 hours after onset of chest pain. When he took 3 – 5 days for the enzyme at levels of peak for clients in the control group, who did not receive thrombolytic agents because of the late arrival to hospital, leading to more damage to the myocardium.

Thus, it is clear that the extent of injury to the myocardium and the oxygen demand is less in the experimental group of customers.

Finally, it May be used as a substitute for late angiographic demonstration of

permeability in future clinical studies of reperfusion therapy. Diagnostic performance improved when the analysis was limited to patients> 6 hours after symptom onset.

CONCLUSION

Clinical studies of fibrinolytic therapy in myocardial infarction show that early thrombolytic treatment starting within 6 hours after the onset of chest pain, decrease the risk of damage and the demand for myocardial oxygen, the process of reduced levels of peak cardiac enzyme levels within 24 hours.

Inj. Metalyse peaked in the early cardiac enzymes in the experimental group reflected Related Artery Infarction open, dissolved the clot by Inj. Metalyse which means that we have good thrombolytic effect, that is why we have a peak in the early levels.

Early identification of patients suffering from persistent occlusion after thrombolyis during

Acute myocardial infarction is also important because it can lead to interventions relief, such as rescue percutaneous transluminal coronary angioplasty or repeated thrombolysis.

NURSING IMPLICATIONS:

SERVICE

Determine the intensity score of angina pectoris

Observe the signs and symptoms

Place patient in a comfortable position

Administer oxygen if necessary

Obtain vital signs every 15 minutes during 2 hours, every half hour for an hour and

every hour for two hours and then if necessary

Obtain 12 Lead Ecg

Monitor for the relief of pain

Monitor Patient response to drug treatment

Institute continuous cardiac monitoring and observation-reperfusion disorders of rhythm, the rhythm changes, bradycardia and tachycardia

Interpreting rhythm strips

Watch complaints of headaches with the use of nitrate

Watch out for repeats of the pain. Reinforce the importance of notification each time the nursing staff pain is felt.

Administer medications to relieve anxiety of the patient according to guidelines such as sedatives and tranquilizers

Complete bed rest for 24 hours

Determine level of activity that precipitated the pain of angina occurs.

Identify specific activities of the patient engaging in May that are below the level of pain of angina is

Prepare for the diagnosis and treatment procedures such as coronary angiography and PTCA [percutaneous transluminal coronary angioplasty]

EDUCATION

Advise on risk factors and lifestyle changes such as —

Methods of stress reduction, such as biofeedback and relaxation techniques

Low fat and low cholesterol diet

Avoid excess caffeine

Do not use diet pills, decongestants nasal

Tracking inspections of diabetes and hypertension

Educate patients and family members as regards —

Prevention of recurrence of pain

Regular use of drugs

Risks of smoking

Prevention of other contributing factors

Regular

Importance of dietary changes

Avoid activities that cause anginal pain, such as sudden effort, walking against the wind, temperature extremes, situations of emotional stress, and avoid engaging physical activity for 2 hours after meals, reducing the weight etc.

The appropriate use of medicines

Side effects of medicines

Administartion

Conduct interdisciplinary intervention programs

The education of students and nurses

Provide training in nursing

Maintenance of records and reports

Maintenance Statistics

Make policies and procedures

Supervision and evaluation of staff representation

Recommendations for further study

A majority of post MI patients do not really participate in cardiac rehabilitation programs is due the lack of structured programs, physician

referrals, low motivation of the patient, non-compliance and financial constraints.

Cardiac rehabilitation provides a venue for continuing education, strengthening

change in lifestyle and adherence to the requirements of

therapies for the recovery of MI, which includes training exercises.

Participation in cardiac rehabilitation programs, after MI with a decrease of

subsequent cardiac morbidity and mortality.

Appropriate education in hospitals and at places of work involved and contributing factors, prevention of heart attacks and cardiac re, is required.

All forms of reperfusion, depending on local facilities must be offered to patients. Protocols must be written and agreed for the strategy reperfusion to be applied within a network. Early diagnosis of ST elevation Myocardial Infarction is essential and is best achieved by the speed of the registration ECG interpretation and the first medical contact, where contact occurs.

About the author:

Pushpa Latha, MSN, Vinayaka Missions University, Selam, Madras, India E-Mail keerthiraksha@yahoo.co.in Ph-00971504277926

Article Source: ArticlesBase.com – Title = "The effect of drugs on cardiac enzymes thrombolytric, creatine kinase and Phospho Creatine Kinase-MB in myocardial Infarctionâ € "> thrombolytric The effect of drugs on cardiac enzymes, creatine kinase and Phospho Creatine Kinase-MB in myocardial Infarctionâ €

New 12 Channels ECG Holter EKG Holter Monitor System $1,099.00

Bionet CardioCare 12 Channel 10 Lead Interpretive ECG, ECG-2000 NEW $1,199.95

New 3 Channels ECG Holter EKG Holter Monitor System $650.00

Edan 12 Channel Print ECG SE-1200 Express $2,800.00

EDAN SE-3B Three Channel ECG Wide Screen Unit-NEW $1,200.00

New 3-channel ECG Holter System/Recorder Monitor ​+ Analyzer Software BID1 $433.00

3 Channels ECG Holter ECG/EKG Holter Monitor System $439.00

Single Channel 1-CH ECG EKG Machine portable handheld $279.00

3-channel Touch Screen 12 LEAD color ECG EKG machine Electrocardiograph Software $679.00

Digital 12 Channel ECG machine,3/6/12 leads ECG CONTEC $1,200.00

Digital 12 Channel ECG EKG Electrocardiograph PCconnect $1,229.00

1-channel 12-lead Electrocardiogragh ECG/ECG machine901 $285.00

Handhold Portable Digital Single 1-Channel ECG EKG machine Electrocardiograph $329.00

New12-Channel ECG EKG Machine 12-lead ECG free shipping $1,020.00

ECG/EKG,Digital Single Channel,electrocardiograph,100G $379.00

3 channel EKG/ECG Electrocardiograph12-lead freeshippin $500.00

3-channel 12 LEAD color ECG EKG machine w PC software $442.99

12 Channel ECG ECG Holter Monitor System Brand New! $738.00

Digital 3 Channel,ECG/EKG Machine,electrocardiograph $599.00

NEW CE Touch Screen 6 channel ECG EKG machine Interpretation Analysis Report $499.00

Portable Touch Screen Digital 6-channel Electrocardiograph ECG EKG machine $450.00

Portable Touch Screen Digital 6-channel Electrocardiograph ECG EKG machine $599.00

NEW 3-channel 12 LEAD color ECG EKG machine w PC software $480.00

3-channel 12 LEAD color ECG EKG machine Electrocardiograph + free PC Software $340.00

NEW CE 3-channel 12 LEAD color ECG EKG machine Electrocardiograph $480.00

Digital Single Channel ECG EKG machine with Printer electrocardiogram ECG-100G $379.00

Brand new Digital 3-channel Electrocardiograph ECG/EKG $425.00

Hand-Held Digital Single Channel ECG Electrocardiograph +Free Software,ECG-80A $279.00

Digital 3 Channel 12 lead ECG/EKG Machine With Free Software, ECG-300G $549.00

New Single channel Ecg Ekg machine Electrocardiograph 1 $389.00

3-channel 12 LEAD color ECG EKG machine FREE SHIPPING $440.00

CE Touch Screen 6 channel ECG EKG machine Interpretation Analysis Report 923 new $650.00

New Digital 6-channel ECG machine 7″ Touch Screen Resting $600.00

Digital 3-channel ECG/EKG Electrocardiograph freeshippi $470.00

ECG/EKG Digital Singel Channel ECG electrocardiogr​aph $265.00

12-channel ECG EKG Holter System Monitor + Recorder​ + Analyze + 1 Year warranty $738.00

Portable Digital 6-channel Electrocardiograph ECG Machine EKG Machine $350.00

NEW 12 Channel ECG holter EKG Holter Monitor System $738.00

2012 Free software Digital 1-channel Handheld Electrocardiograph ECG/EKG Machine $329.00

Brand New 3 Channel EKG ECG HOLTER Monitoring System $1,580.00

Single 1-channel Handheld Electrocardiograph ECG EKG $260.00

VET Handheld 1-channel ECG/EKG machine for animal diagnose Home clinical use CE $329.00

Portable Handheld Single Channel ECG EKG Machine New!!! $281.00

Handheld ECG /EKG machine Electrocardiograph with printer single channel $329.00

New 12-Channel ECG EKG Machine Electrocardiograph 5.7″ $1,019.00

New Veterinary VET 1 channel EKG ECG Electrocardiograph for Animail $455.00

Vet one channel ECG/EKG Electrocardiograph veterinary $349.00

Veterinary VET 1 channel EKG ECG Electrocardiograph NEW $399.00

12 Channels ECG ECG Holter Monitor System Brand New! $752.00

12 Channels ECG ECG Holter Monitor System Brand New! $750.00

Welch Allyn CP300 12 Channel Interpretive ECG $7,900.00

Welch Allyn CP300 12 Channel Interpretive ECG w Stress $13,750.00

6 Channel Edan ECG-EKG Brand New ! $1,585.00

CMS-80A Hand-Held Single Channel ECG $339.99

CMS-80A Hand-Held Single Channel ECG for Vet use $339.99

12 channel Color ECG EKG Holter Recorder Holter Monitor $899.00

new Veterinary vet 1 channel Single Channel ECG EKG machine Electrocardiograph $350.00

Newest Version 3-channel ECG Holter System/Recorder Monitor ​+Free Analyzer Sw $439.00

ECGLAB ECG Analyzer+3-channel Color LCD Holter Recorder $394.00

CE and NEW Vet Veterinary 1-channel Electrocardiograph ECG/EKG machine $180.00

CE Vet 1-channel Electrocardiograph ECG/EKG machine -80V CF-07 $329.00

VET used handheld 1-CHANNEL ECG EKG Machine Veterinary $260.00

2012 CE Proved 3-Channel 12-lead ECG/EKG Machine Electrocardiograph W $450.00

2012 CE Proved 3-channel 12 LEAD color ECG EKG machine+ PC software $460.01

2012 CE Proved Digital 6-channel Handheld Electrocardiograph ECG/EKG Machine $599.00

2012 Newest CE Proved 3-channel 12 LEAD color ECG EKG machine + PC software $380.01

2012 Newest CE Proved Single 1-channel Handheld Electrocardiograph ECG EKG $278.00

2012 Newest CE Proved Single channel Ecg/Ekg machine Electrocardiograph NEW $305.00

2012 Newest CE Proved Digital 1 Channel Electrocardiograph ECG/EKG Machine $300.00

EDAN SE-1010 PC-BASED ECG/EKG 12 CHANNEL KIT. USB CONNECTION .FDA APPROVED $1,900.00

3 Channels ECG Holter ECG/EKG Holter Monitor System $650.00

New CE&FDA Certified Hand-Held Single Channel ECG EKG Monitor with USB Software $279.00

1 channel EKG ECG machine 12 Lead Electrocardiograph $369.00

Digital 12 channel ECG/EKG machine Electrocardiograph free PC softwear $960.00

ECG100G Single Channel Portable ECG EKG Machine Sells Promotion $199.00

ECG-300G Digital 3 Channel 12 lead ECG/EKG machine free softwar+ Free Software $569.00

Single channel Ecg/Ekg machine Electrocardiograph NEW $265.00

New 3 Channels 12 leads Digital ECG / EKG Machine,+ Printer+ USB Cable&Software $649.00

Veterinary ECG EKG 1-channel Vet Electrocardiograph $229.00

Datrix 3 channel Holter ECG Recorder xr-300 USEd $499.00

Digital 3 Channel 12 lead ECG EKG machine free software $649.00

Dual Channel Audio Output Amplifier TDA2005 ECG 1396 $4.95

NEW 3-Channel ECG EKG Machine Electrocardiograph EKG-903A proffessional $509.00

Brand new Digital 12-channel ECG/EKG Electrocardiograph $1,119.00

12 Channel ECG Holter System ECG/EKG Recorder/Analyz​er $1,099.00

ECG 100G Single Channel Portable ECG/EKG machine with printer $379.00

Burdick 007036 Single Channel ECG Mounts Elite Folder Pressure Sensitive $24.99

2012 Brand NEW 12 Channel ECG holter EKG Holter Monitor System +FREE SHIPPING $738.00

CE and NEW Vet Veterinary 1-channel Electrocardiograph ECG/EKG machine -80V $260.00

Digital 6-channel Handheld Electrocardiograph ECG $739.00

Handhold Portable Digital Single 1-Channel ECG EKG machine Electrocardiograph $200.00

Handheld Single Channel ECG /EKG machine Electrocardiograph SOFTWARE + printer $329.00

Handheld Single Channel ECG /EKG machine Electrocardiograph $303.00

ECG 300G Digital 3-channel 12 lead ECG/EKG machine free software $440.00

7-inch Color LCD Portable Digital 3-channel 12-lead Electrocardiograph ECG/EKG $679.00

Portable Digital 12-channel Electrocardiograph ECG Machine EKG Machine EKG-1212A $989.00

Digital 1-channel Electrocardiograph 12-lead ECG signal LCD display $275.00

ECG Holter System 3 Channel Holter Recorder/Analyzer $429.00

3 Channels ECG Holter ECG/EKG Holter Monitor System $439.00

Newest Version 3-channel ECG Holter System/Recorder Monitor ​+Free Analyzer Sw $275.00

---

Rolling stand for Welch Allyn Spot vital sign minotor LXI , free shipping in continental USA, $299.00 Rolling stand for Welch Allyn Spot vital sign minotor LXI 23- 43 inch height adjustable . upper bucket standard optional lower bucket and laptop computer holder….

HEALTHPOWER Three Channel Interpretive ECG ECG unit Three Channel Interpretive ECG and standard 12 leads Inner handhold designed for portability and Light Weight Designed with a high-resolution thermal printer to print out ECG waveform, annotation as well related parameters for diagnosis reference. Roll recording paper for ECG-813 is 63mm in width and 30m in length. Simultaneously acquisition of 12 lead ECG data, IEC Class, type CE safety standard….

007981HSI PT# 1025507 Paper EKG/ECG Burdick 007981 1-Channel 216mm HSI RedGrid 300/Pk Manufactured by Henry Schein $23.14 …

SockGuy Men’s Ch Air Hetri Socks $10.95 Tri (verb)- To Be Put To The Test. Our Channel-Air(tm) socks are designed with 5 channels of padded cushioning where you need it, and 4 channels of mesh for increased air flow. Typical padded socks have more bulk in the foot that increases heat build-up and puts undue stress on the moisture management system. We have solved that problem with the introduction of 4 channels of air-mesh eliminating n…

Magic: the Gathering – Snapsail Glider – Scars of Mirrodin $0.01 Magic: the Gathering is a collectible card game created by Richard Garfield. In Magic, you play the role of a planeswalker who fights other planeswalkers for glory, knowledge, and conquest. Your deck of cards represents all the weapons in your arsenal. It contains the spells you know and the creatures you can summon to fight for you. Card Name: Snapsail Glider Cost: 3 Color: Artifact Card Type: Ar…

Magic: the Gathering – Restless Apparition – Eventide $0.10 Magic: the Gathering is a collectible card game created by Richard Garfield. In Magic, you play the role of a planeswalker who fights other planeswalkers for glory, knowledge, and conquest. Your deck of cards represents all the weapons in your arsenal. It contains the spells you know and the creatures you can summon to fight for you. Card Name: Restless Apparition Cost: (W/B)(W/B)(W/B) Color: Mult…

Axxess MITO-01 Amplifier Interface Harness $95.00 To be Used in Vehicles Listed that have a Rockford Fosgate Audio SystemInterface Component with 14-Pin Harness and RCA ConnectorsVehicle Side HarnessCommunication from Interface to Continue Working with Aftermarket RadiosAdjustable Input Gain to Adapt a Variety of Aftermarket Radio OutputsInterface is USB Updatable to Combat Application and Technology Changes…

Ekg Machine & Free Microscope …

Schiller Cardiovit At-1, 3 Channel, 12 Lead ECG System with Interpretation (Same DAY Shipping) $1,319.95 Cardiovit AT-1 ECG with Interp. software incl. Accessory kit. One (1) Year Limited Warranty. Included Accessories:? 10 Lead Patient Cable? 10 Snap Clip Electrode Adapters? 500 Disposable Electrodes? One (1) pack of paper? Power Cable? Operating ManualModel Number: 9.190000C…

---